The effect of inadequate initial empiric antimicrobial treatment on mortality in critically ill patients with bloodstream infections: A multi-centre retrospective cohort study

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Savage, Rachel D ^a,b   Fowler, Robert A ^b,c,d   Rishu, Asgar H ^b   Bagshaw, Sean M ^e   Cook, Deborah ^f   Dodek, Peter ^g,h   Hall, Richard ^i,j   Kumar, Anand ^k   Lamontagne, François ^l,m   Lauzier, François ^n,o   Marshall, John ^a,p   Martin, Claudio M ^q,r   McIntyre, Lauralyn ^s   Muscedere, John ^t,u   Reynolds, Steven ^g   Stelfox, Henry T ^v   Daneman, Nick ^b,c,d,w  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h ST PAUL S HOSPITAL   (Canada)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

^j NOVA SCOTIA HEALTH AUTHORITY   (Canada)

^k UNIVERSITY OF MANITOBA   (Canada)

^l CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^m UNIVERSITÉ DE SHERBROOKE   (Canada)

ⁿ University Laval   (Canada)

^o UNIVERSITÉ LAVAL   (Canada)

^p ST MICHAEL'S HOSPITAL   (Canada)

^q UNIVERSITY OF WESTERN ONTARIO   (Canada)

^r LONDON HEALTH SCIENCES CENTRE   (Canada)

^s UNIVERSITY OF OTTAWA   (Canada)

^t QUEEN S UNIVERSITY   (Canada)

^u KINGSTON GENERAL HOSPITAL   (Canada)

^v UNIVERSITY OF CALGARY   (Canada)

^w INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CANADA; CANDIDEMIA; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ESCHERICHIA COLI; FEMALE; GENERAL ASPECTS OF DISEASE; HUMAN; IN HOSPITAL MORTALITY; INADEQUATE INITIAL EMPIRIC ANTIMICROBIAL TREATMENT; INFECTION SOURCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; STAPHYLOCOCCUS AUREUS; THERAPY DELAY; TIME TO TREATMENT; AGED; CLINICAL TRIAL; FUNGEMIA; HOSPITAL MORTALITY; MULTICENTER STUDY;

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTEREMIA; CANADA; FEMALE; FUNGEMIA; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84968659761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154944     Document Type: Article

References (40)

1. Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013; 19: 501-509. doi: 10.1111/1469-0691.12195 PMID: 23473333
2. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81: 1159-1171. PMID: 16970212
3. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009; 302: 2323-2329. doi: 10.1001/jama.2009.1754 PMID: 19952319
4. Garrouste-Orgeas M, Timsit JF, Tafflet M, Misset B, Zahar JR, Soufir L, et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis. 2006; 42: 1118-1126. PMID: 16575729
5. Laupland KB, Lee H, Gregson DB, Manns BJ. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect. 2006; 63: 124-132. PMID: 16621137
6. Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy. 2005; 51: 171-176. PMID: 15980627
7. McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP Jr, et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis. 2007; 45: 329-337. PMID: 17599310
8. Adam HJ, DeCorby M, Rennie R, Karlowsky JA, Hoban DJ, Zhanel GG, et al. Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis. 2011; 69: 307-313. doi: 10.1016/j.diagmicrobio.2010.10.026 PMID: 21353958
9. Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis. 2014; 78: 443-448. doi: 10.1016/j.diagmicrobio.2013.11.025 PMID: 24492025
10. Peralta G, Sanchez MB, Garrido JC, De Benito I, Cano ME, Martinez-Martinez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother. 2007; 60: 855-863. PMID: 17644532
11. Daneman N, Rishu AH, Xiong W, Bagshaw SM, Dodek P, Hall R, et al. Antibiotic treatment durations among Canadian critically ill patients with bacteremia. Crit Care Med. 2015;In press.
12. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005; 111: e394-434. PMID: 15956145
13. Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med. 2010; 362: 1022-1029. doi: 10.1056/NEJMcp0910753 PMID: 20237348
14. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004; 351: 1645-1654. PMID: 15483283
15. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50: 133-164. doi: 10.1086/649554 PMID: 20034345
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13: 818-829. PMID: 3928249
17. de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT, et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis. 2011; 11: 372-380. doi: 10.1016/S1473-3099(11)70035-4 PMID: 21420908
18. Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE, editors. Regression methods in biostatistics. 2nd ed. New York: Springer; 2012.
19. Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003; 9: 412-418. PMID: 12848754
20. Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, et al. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect Dis. 2008; 8: 116-2334-8-116.
21. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005; 49: 760-766. PMID: 15673761
22. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother. 2007; 60: 613-618. PMID: 17576697
23. Tumbarello M, Posteraro B, Trecarichi EM, Fiori B, Rossi M, Porta R, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol. 2007; 45: 1843-1850. PMID: 17460052
24. Almirante B, Rodriguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005; 43: 1829-1835. PMID: 15815004
25. Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012; 54: 1739-1746. doi: 10.1093/cid/cis305 PMID: 22423135
26. Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, et al. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis. 2010; 10: 150-2334-10-150.
27. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000; 118: 146-155. PMID: 10893372
28. Harbarth S, Ferriere K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg. 2002; 137: 1353-9; discussion 1359. PMID: 12470098
29. Chahoud J, Kanafani ZA, Kanj SS. Management of candidaemia and invasive candidiasis in critically ill patients. Int J Antimicrob Agents. 2013; 42 Suppl: S29-35. doi: 10.1016/j.ijantimicag.2013.04.008 PMID: 23664579
30. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006; 43: 25-31. PMID: 16758414
31. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005; 49: 3640-3645. PMID: 16127033
32. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34: 1589-1596. PMID: 16625125
33. Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD, et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis. 2012; 12: 774-780. doi: 10.1016/S1473-3099(12)70151-2 PMID: 22951600
34. Schuster MG, Edwards JE Jr, Sobel JD, Darouiche RO, Karchmer AW, Hadley S, et al. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med. 2008; 149: 83-90. PMID: 18626047
35. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2011; 49: 665-670. doi: 10.1128/JCM.01602-10 PMID: 21106797
36. Bloos F, Bayer O, Sachse S, Straube E, Reinhart K, Kortgen A. Attributable costs of patients with candidemia and potential implications of polymerase chain reaction-based pathogen detection on antifungal therapy in patients with sepsis. J Crit Care. 2013; 28: 2-8. doi: 10.1016/j.jcrc.2012.07.011 PMID: 22999484
37. Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1 - >3)-beta-D-glucan assay, Candida score, and colonization index. Crit Care. 2011; 15: R249. doi: 10.1186/cc10507 PMID: 22018278
38. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004; 39: 199-205. PMID: 15307029
39. Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care. 2011; 15: R287. doi: 10.1186/cc10574 PMID: 22126425
40. Sexton DJ, Miller BA, Anderson DJ. Measuring the effect of inappropriate initial antibiotic therapy on outcomes of patients with Gram-negative sepsis: An imprecise science. Crit Care Med. 2011; 39: 199-200. doi: 10.1097/CCM.0b013e318202e68f PMID: 21178535